Healing the health workforce: A call to action for EU institutions
Civil organisations, patients’ advocacy groups and healthcare professional associations urge European policymakers to address the health workforce crisis by implementing solutions that prioritise the well-being of health workers.
|
ESWI Respiratory Virus Summit 2024
ESWI Summit 2024: Conclusions
Conclusions by Peter Openshaw, Co-Chair of the the ESWI Respiratory Virus Summit 2024
|
ESWI Respiratory Virus Summit 2024
ESWI Summit 2024: Science Policy Interface debate
How to ensure/prepare for access to immunisation programmes
|
ESWI Respiratory Virus Summit 2024
ESWI Summit 2024: Rapporteur from the RSVVW’ 2024 meeting in Mumbai
By Ab Osterhaus, Host of the ESWI Respiratory Virus Summit 2024
|
ESWI Respiratory Virus Summit 2024
ESWI Summit 2024: What's in the pipeline?
Live attenuated vaccines; NIRSE-GAL: Evaluation of the effectiveness and impact of Nirsevimab in Galicia; and Therapeutics
|
ESWI Respiratory Virus Summit 2024
ESWI Summit 2024: Early Career Scientists
ESWI Summit 2024: Early Career Scientists They each delivered a presentation introducing themselves and their ongoing work on RSV, bringing innovative ideas and making clear calls for action.
|
ESWI Respiratory Virus Summit 2024
ESWI Summit 2024: Diagnostics and Point of Care Testing
Keynote Lecture by Dexter Wiseman, Imperial College London
|
ESWI Respiratory Virus Summit 2024
ESWI Summit 2024: Burden of disease in older adults
Keynote Lecture by Stefan Gravenstein, Brown University
|
ESWI Respiratory Virus Summit 2024
ESWI Summit 2024: Burden of disease in infants
Keynote Lecture by Simon Drysdale, St George's University Hospitals NHS Foundation Trust
Diabetes Community Pledge for the European Parliament Elections 2024
Sign the Diabetes Community Pledge to support the 32 million people living with diabetes in the European Union and their families. Take action by creating a strong EU diabetes policy framework supportive of national diabetes action plans.
First results in using new tools to tackle respiratory syncytial virus
Protecting infants from RSV with new tools: vaccines for pregnant women and use of monoclonal antibodies have been approved for use in the European Union to prevent RSV among young children. Are those tools working?
News
Policy & Recommendations
Flash Report: Third meeting of the Public Health Expert Group (PHEG)
Chaired by DG SANTE, EU Member States agreed on prioritising for 2024-2026: health promotion & prevention of non-communicable diseases; healthy longevity/lifelong prevention; vaccine-preventable diseases & vaccination; and long COVID, amongst others.